Works matching IS 00070920 AND DT 2025 AND VI 132 AND IP 1
Results: 14
Commentary to: Cancer and treatment specific incidence rates of immune related adverse events induced by immune checkpoint inhibitors: a systematic review: Clinical Studies.
- Published in:
- British Journal of Cancer, 2025, v. 132, n. 1, p. 49, doi. 10.1038/s41416-024-02933-y
- By:
- Publication type:
- Article
Correction: Cancer and treatment specific incidence rates of immune-related adverse events induced by immune checkpoint inhibitors: a systematic review.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
Editorial Expression of Concern: Clusterin inhibition using OGX-011 synergistically enhances antitumour activity of sorafenib in a human renal cell carcinoma model.
- Published in:
- British Journal of Cancer, 2025, v. 132, n. 1, p. 138, doi. 10.1038/s41416-024-02918-x
- By:
- Publication type:
- Article
Pregabalin for chronic cough due to lung cancer: randomized, double-blind, placebo-controlled trial: Clinical Studies.
- Published in:
- British Journal of Cancer, 2025, v. 132, n. 1, p. 58, doi. 10.1038/s41416-024-02913-2
- By:
- Publication type:
- Article
SKP2 inhibition activates tumor cell-intrinsic immunity by inducing DNA replication stress and genomic instability: Cellular and Molecular Biology.
- Published in:
- British Journal of Cancer, 2025, v. 132, n. 1, p. 81, doi. 10.1038/s41416-024-02909-y
- By:
- Publication type:
- Article
Associations of blood lipids and LDL cholesterol lowering drug-targets with colorectal cancer risk: a Mendelian randomisation study: Epidemiology.
- Published in:
- British Journal of Cancer, 2025, v. 132, n. 1, p. 103, doi. 10.1038/s41416-024-02900-7
- By:
- Publication type:
- Article
UK guidelines for the management of soft tissue sarcomas: Clinical Studies.
- Published in:
- British Journal of Cancer, 2025, v. 132, n. 1, p. 11, doi. 10.1038/s41416-024-02674-y
- By:
- Publication type:
- Article
Real-world evidence for pembrolizumab in non-small cell lung cancer: a nationwide cohort study: Epidemiology.
- Published in:
- British Journal of Cancer, 2025, v. 132, n. 1, p. 93, doi. 10.1038/s41416-024-02895-1
- By:
- Publication type:
- Article
IL-10RA governor the expression of IDO in the instruction of lymphocyte immunity: Translational Therapeutics.
- Published in:
- British Journal of Cancer, 2025, v. 132, n. 1, p. 126, doi. 10.1038/s41416-024-02893-3
- By:
- Publication type:
- Article
VEGF-C propagates 'onward' colorectal cancer metastasis from liver to lung: Cellular and Molecular Biology.
- Published in:
- British Journal of Cancer, 2025, v. 132, n. 1, p. 69, doi. 10.1038/s41416-024-02892-4
- By:
- Publication type:
- Article
Cancer and treatment specific incidence rates of immune-related adverse events induced by immune checkpoint inhibitors: a systematic review: Epidemiology.
- Published in:
- British Journal of Cancer, 2025, v. 132, n. 1, p. 51, doi. 10.1038/s41416-024-02887-1
- By:
- Publication type:
- Article
UK guidelines for the management of bone sarcomas: Clinical Studies.
- Published in:
- British Journal of Cancer, 2025, v. 132, n. 1, p. 32, doi. 10.1038/s41416-024-02868-4
- By:
- Publication type:
- Article
Integrated proteomics and scRNA-seq analyses of ovarian cancer reveal molecular subtype-associated cell landscapes and immunotherapy targets: Molecular Diagnostics.
- Published in:
- British Journal of Cancer, 2025, v. 132, n. 1, p. 111, doi. 10.1038/s41416-024-02894-2
- By:
- Publication type:
- Article
Gastrointestinal stromal tumour (GIST): British Sarcoma Group clinical practice guidelines: Clinical Studies.
- Published in:
- British Journal of Cancer, 2025, v. 132, n. 1, p. 1, doi. 10.1038/s41416-024-02672-0
- By:
- Publication type:
- Article